Navigation Links
American Heart Association conference highlights solutions for reducing sodium intake
Date:6/11/2014

11 June 2014 Sodium intake around the world continues to be of concern1 and public health authorities hypothesise that it may be linked with cardiovascular disease risk2. In an effort to identify ways to reduce the amount of sodium consumed and provided in the food supply, the American Heart Association brought together over 100 key stakeholders and thought leaders at a special conference in June 2013. Proceedings from the conference were published in the May 2014 edition of Circulation3.

Among the top priorities identified by the group were increasing consumer understanding for the need to reduce sodium intake and the use of food technologies to reduce sodium in the food supply as much as possible. In an effort to advance sodium reduction technology, Tate & Lyle showcased an ingredient at the conference, SODA-LO Salt Microspheres, which has the potential to be a major contributor for reducing sodium in the marketplace.

According to the American Heart Association publication, new food technologies, like SODA-LO Salt Microspheres, can lower the sodium content of foods and are one part of the solution for meeting public health recommendations3.

Sodium Reduction Innovation: SODA-LO Salt Microspheres

SODA-LO Salt Microspheres is a salt-reduction ingredient that tastes, functions, and may label* like salt because it is salt. It can reduce sodium by 25 to 50% in food applications such as bread and salty snacks. SODA-LO is created using a patented technology that transforms standard salt crystals into free-flowing, hollow salt microspheres that efficiently deliver salty taste by maximising surface area relative to volume.

Research presented at the conference showed the potential impact of replacing salt with SODA-LO on overall sodium intake. Using US National Health and Nutrition Examination Survey (NHANES) 2007-2010 data3, the potential usage of SODA-LO in 953 foods allowing 20-30% sodium reduction was modelled assuming a 50 or 100% market penetration. Results of the dietary modelling demonstrated that sodium intakes could decrease by 4% to 9% across age, sex, and ethnic groups. This reduction is equivalent to 130 to 360 mg/day. SODA-LO Salt Microspheres can serve as one solution to help decrease population sodium intake. While changing consumer palates for foods lower in sodium may require significant time4, interim technologies like SODA-LO can provide an immediate solution for sodium intake reduction.

'Tate & Lyle, as a leader in sodium reduction technology, can offer food manufacturers a novel, great tasting ingredient that can be used in products that consumers will enjoy and continue to demand,' stated Mike Harrison, Senior Vice President of New Product Development at Tate & Lyle.

SODA-LO Salt Microspheres is the result of Tate & Lyle's Open Innovation team that creates partnerships to bring the most exciting new food ingredient technologies to market. Through a license agreement with Eminate, a wholly owned subsidiary of the University of Nottingham, UK, Tate & Lyle has exclusive, worldwide rights for product development, manufacturing and commercialisation of the SODA-LO Salt Microspheres technology.

*Labelling rules vary from country to country.


'/>"/>

Contact: Allison Parker
PRenquiries@tateandlyle.com
312-258-9500 x112
FoodMinds LLC
Source:Eurekalert

Related biology news :

1. American College of Rheumatology releases first classification criteria for polymyalagia rheumatica
2. Common North American frog identified as carrier of deadly amphibian disease
3. UC research tests new tool to guide reintroduction of the American chestnut
4. American Society of Plant Biologists honors early career women scientists
5. Scripps Research Institute Professor Gerald F. Joyce elected to American Academy of Arts & Sciences
6. Professor known for work with hunter-gatherers elected to American Academy of Arts and Sciences
7. Elsevier selected as new publisher of the American Journal of Geriatric Psychiatry
8. New study published on fertility awareness among American university students
9. The American Society for Microbiology honors Ellen Jo Baron
10. Steve Fisher joins American Health IT LLC as VP of Operations
11. University of Tennessee anthropologists find American heads are getting larger
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/24/2016)... 2016 Ampronix facilitates superior patient care by providing unparalleled technology to leaders ... is the latest premium product recently added to the range of products distributed by ... ... ... LCD Medical Display- Ampronix News ...
(Date:5/16/2016)...   EyeLock LLC , a market leader of ... an IoT Center of Excellence in Austin, ... of embedded iris biometric applications. EyeLock,s iris ... security with unmatched biometric accuracy, making it the most ... EyeLock,s platform uses video technology to deliver a fast ...
(Date:5/9/2016)... Elevay is currently known as ... for high net worth professionals seeking travel for work ... world, there is still no substitute for a face-to-face ... your deal with a firm handshake. This is why ... of citizenship via investment programs like those offered by ...
Breaking Biology News(10 mins):
(Date:6/27/2016)... PHILADELPHIA , June 27, 2016  Liquid ... today announced the funding of a Sponsored Research ... study circulating tumor cells (CTCs) from cancer patients.  ... changes in CTC levels correlate with clinical outcomes ... therapies. These data will then be employed to ...
(Date:6/24/2016)... DIEGO , June 24, 2016 ... more sensitively detects cancers susceptible to PARP inhibitors ... circulating tumor cells (CTCs). The new test has ... HRD-targeted therapeutics in multiple cancer types. ... targeting DNA damage response pathways, including PARP, ATM, ...
(Date:6/23/2016)... ... June 23, 2016 , ... Mosio, a ... eBook, “Clinical Trials Patient Recruitment and Retention Tips.” Partnering with experienced clinical research ... by providing practical tips, tools, and strategies for clinical researchers. , “The landscape ...
(Date:6/23/2016)... , June 23, 2016 /PRNewswire/ - FACIT ... Ontario biotechnology company, Propellon Therapeutics ... development and commercialization of a portfolio of first-in-class ... Epigenetic targets such as WDR5 represent an exciting ... significantly in precision medicine for cancer patients. Substantial ...
Breaking Biology Technology: